Developed to serve primarily as a litigation scouting report for plaintiff and defense counsel, insurers and legal service providers, HarrisMartin’s MDL Mass Tort & Class Action Monitor covers significant new filings and decisions in the JPML, MDL and related mass tort arenas. The quick delivery of breaking news and additional features will keep you within close range of every development occurring in the high-stakes environment of mass torts litigation — where minutes can make a difference. The MDL Mass Tort & Class Action Monitor is an online-only offering that includes frequent email updates and is available at no charge to annual and event sponsors of HarrisMartin’s CLE Conferences.
Download a publication order form here or subscribe here.
MDL Mass Tort & Class Action Monitor - Issue: 48
Gardasil MDL Judge Will Hear Vaccine Act Preemption Arguments at Upcoming Hearing
Zofran MDL Plaintiffs Ordered to Pay GSK $453,989 in Costs
Class Action Claims Arising from Drug Shortage Untimely, 1st Cir. Rules
Plaintiffs’ Leadership Proposed in Suboxone Film Decay MDL
Social Media MDL Defendants Say General Negligence Claim Barred by Section 230
9th Cir. Upholds Approval of $90 Million Settlement in Facebook Privacy MDL
Gilead Immune from Class Action Claims Targeting COVID-19 Drug Veklury, Judge Rules
LifeCell Must Face Trial in N.J. Bellwether Strattice Hernia Mesh Case, Judge Rules
